A shared protocol for porcine surfactant use in pediatric acute respiratory distress syndrome: a feasibility study

Table 3 Analysis of variables associated with mortality (univariate logistic regression)

Associated variables	OR	CI	p value
Weight	1.072	0.84–1.37	0.583
Age	1.002	0.99–1.01	0.183
Gender, M	1.364	0.37–5.00	0.640
Immaturity	1.538	0.29–8.09	0.611
CCC	0.072	0.01–0.38	0.002
HFOV	5.5	1.40–21.52	0.015
ECMO	3	0.48–18.85	0.241
P-S	0.308	0.06–1.48	0.142
iNO	2.619	0.69–9.91	0.156
Time Interval adm – surf	1.142	1.02–1.28	0.025
PaCO₂, pre administration	1.025	0.98–1.07	0.268
PaO₂, pre administration	0.981	0.94–1.03	0.405
FiO₂, pre administration	259.236	1.12–5989	0.045
P/F, pre administration	0.97	0.94–1.00	0.066
pH, pre administration	2.451	0.01–829.4	0.763
OI, pre administration	1.023	0.97–1.07	0.369

OR odds ratio, CI confidence interval, M male, CCC Chronic Complex Condition, HFOV high frequency oscillatory ventilation, P-S prono supination, iNO inhaled nitric oxide, OI oxygenation index, d day, adm admission, surf surfactant dose

ISSN: 1471-2431